Stocks and InvestingStocks and Investing
Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023

Jonathan Wolleben Reiterated (ALT) at Buy and Held Target at $15 on, Mar 31st, 2023


Published on 2024-10-28 02:31:03 - WOPRAI, Jonathan Wolleben
  Print publication without navigation


Jonathan Wolleben of JMP Securities, Reiterated "Altimmune, Inc." (ALT) at Buy and Held Target at $15 on, Mar 31st, 2023.

Jonathan has made no other calls on ALT in the last 4 months.



There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 1 agrees with Jonathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Corinne Jenkins of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, March 22nd, 2023


These are the ratings of the 2 analyists that currently disagree with Jonathan


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Thursday, March 9th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Wednesday, January 18th, 2023